Stated Preference for Cancer Screening: A Systematic Review of the Literature, 1990-2013

• Published in: Preventing chronic disease 2016-02, Vol.13, p.E27-E27, Article 150433
• Main Authors: Mansfield, Carol, Tangka, Florence K L, Ekwueme, Donatus U, Smith, Judith Lee, Guy, Jr, Gery P, Li, Chunyu, Hauber, A Brett
• Format: Article
• Language: English
• Subjects: Breast Neoplasms - diagnosis; Choice Behavior; Colorectal Neoplasms - diagnosis; Delivery of Health Care - standards; Early Detection of Cancer - methods; Female; Humans; Mass Screening - methods; Patient Preference; Surveys and Questionnaires; Systematic Review; Uterine Cervical Neoplasms - diagnosis
• ISSN: 1545-1151; 1545-1151
• DOI: 10.5888/pcd13.150433

Stated-preference methods provide a systematic approach to quantitatively assess the relative preferences for features of cancer screening tests. We reviewed stated-preference studies for breast, cervical, and colorectal cancer screening to identify the types of attributes included, the use of questions to assess uptake, and whether gaps exist in these areas. The goal of our review is to inform research on the design and promotion of public health programs to increase cancer screening. Using the PubMed and EconLit databases, we identified studies published in English from January 1990 through July 2013 that measured preferences for breast, cervical, and colorectal cancer screening test attributes using conjoint analysis or a discrete-choice experiment. We extracted data on study characteristics and results. We categorized studies by whether attributes evaluated included screening test, health care delivery characteristics, or both. Twenty-two studies met the search criteria. Colorectal cancer was the most commonly studied cancer of the 3. Fifteen studies examined only screening test attributes (efficacy, process, test characteristics, and cost). Two studies included only health care delivery attributes (information provided, staff characteristics, waiting time, and distance to facility). Five studies examined both screening test and health care delivery attributes. Overall, cancer screening test attributes had a significant effect on a patient's selection of a cancer screening test, and health care delivery attributes had mixed effects on choice. A growing number of studies examine preferences for cancer screening tests. These studies consistently find that screening test attributes, such as efficacy, process, and cost, are significant determinants of choice. Fewer studies have examined the effect of health care delivery attributes on choice, and the results from these studies are mixed. There is a need for additional studies on the barriers to cancer screening uptake, including health care delivery attributes, and the effect of education materials on preferences.